Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Vilanterol Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115286491A reveals a novel crystallization-based route for 2-[2-(6-bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene, offering superior purity and scalability for global supply chains.
Patent CN103923058A details a safer vilanterol intermediate route avoiding toxic catalysts, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel one-pot method for vilanterol intermediate fumarate. High purity, reduced waste, cost-effective manufacturing for COPD pharmaceutical supply chains.
Novel one-pot method for Vilanterol intermediate fumarate. Reduces solvent waste, improves purity to >99.8%, and ensures scalable supply chain reliability for global pharma partners.
Patent CN116024187B enables enzymatic synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis of Vilanterol intermediate CN105646285A offers higher yield and cost efficiency. Reliable pharmaceutical intermediates supplier for global supply chains.